Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Pharmacology

Background:

• Curcuminoids are natural compounds with potential anticancer properties.
• Developing synthetic curcuminoid analogs can enhance therapeutic efficacy.
• Halogenated bis(4-methoxy/4,5-dimethoxybenzylidene)-4-piperidone structures represent a promising class of compounds.

Purpose of the Study:

• To synthesize and evaluate novel halogenated curcuminoid derivatives.
• To assess the cytotoxic and antiproliferative effects on human cancer cell lines.
• To investigate the mechanisms of action, including apoptosis induction and cell cycle arrest.

Main Methods:

• Synthesis of curcuminoid derivatives with halogenated bis(4-methoxy/4,5-dimethoxybenzylidene)-4-piperidone structures.
• Cytotoxicity assays on eight human cancer cell lines.
• Analysis of reactive oxygen species (ROS) production and apoptosis.
• Cell cycle analysis using flow cytometry.
• Inhibition of colony formation assays.
• In vivo antiangiogenesis assays in zebrafish embryos.
• In vivo efficacy studies in colon cancer xenograft models.

Main Results:

• Compounds 2a and 3c exhibited stronger antiproliferative activity than EF24 against six cancer cell lines.
• Compounds 2a and 3c induced reactive oxygen species and apoptosis in melanoma cells.
• Compound 2a caused G1 cell cycle arrest, while 3c induced G2/M arrest and MMP-2 downregulation.
• Both compounds inhibited colony formation in HCT116 cells and demonstrated antiangiogenic activity.
• Compound 3c was well-tolerated in mice and inhibited HCT116 tumor growth.

Conclusions:

• Novel halogenated curcuminoids display significant anticancer potential.
• Compounds 2a and 3c are promising candidates for further cancer therapeutic development.
• The observed mechanisms include apoptosis induction, cell cycle arrest, and antiangiogenesis.